Lucid Diagnostics 旗下 Esoguard® 食管DNA检测获多项商业健康保险覆盖政策支持

美股速递
Aug 05

Lucid Diagnostics 公司近日宣布,其推出的 Esoguard® 食管DNA检测产品已成功获得覆盖多项商业健康保险计划的政策支持。这一里程碑式的进展,意味着该检测项目将正式纳入多个保险计划的报销范围,从而有望大幅提升患者对这项关键筛查技术的可及性。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10